A. J. Kazimi - 17 Mar 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
17 Mar 2021
Net transactions value
-$81,627
Form type
4
Filing time
11 Jun 2021, 17:14:58 UTC
Next filing
10 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Tax liability $120,267 -37,350 -0.64% $3.22 5,755,719 17 Mar 2021 Direct F1
transaction CPIX Common Stock Award $38,640 +12,000 +0.21% $3.22 5,767,719 17 Mar 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Award $0 +88,000 $0.000000 88,000 17 Mar 2021 Common Stock 88,000 $3.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
F2 Restricted stock award will vest 100% on March 17, 2025.
F3 100% vesting on March 17, 2025.